Author:
Wani VivekBasavprabhu,Agarwal Ankita,Tenagi ArvindL,Khanagavi Bhagyajyothi,Bubanale ShivanandChannabasu,Chougule Nagbhushan,Warad Chethana
Reference19 articles.
1. Ranibizumab and bevacizumab for neovascular age-related macular degeneration;CATT;N Engl J Med,2011
2. Long-term outcomes of ranibizumab therapy for diabetic macular edema: The 36-month results from two phase III trials: RISE and RIDE;Brown;Ophthalmology,2013
3. Brown DM, Heier JS, Clark WL, Boyer DS, Vitti R, Berliner AJ, et al. Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study. Am J Ophthalmol 2013;155:429-37.e7.
4. Panretinal photocoagulation versus intravitreous ranibizumab for proliferative diabetic retinopathy: A randomized clinical trial;Writing;JAMA,2015
5. Use of retinal procedures in medicare beneficiaries from 1997 to 2007;Ramulu;Arch Ophthalmol,2010